All PROTECT study Articles
-
849Latest Myopia NewsVTI’s NaturalVue Six-Year Data Confirmed by Three Independent Studies
September 8, 2023 CHICAGO — Visioneering Technologies Inc. completed a six-year clinical trial for its NaturalVue Multifocal (MF) contact lenses, and now,...
-
883Latest Myopia NewsVTI’s PROTECT Study Reaches 100% Enrollment
December 7, 2022 ATLANTA — Visioneering Technologies Inc.’s PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) study has officially reached 100% participant enrollment....
-
974Latest Myopia NewsVTI Reaches 50% Enrollment Milestone for PROTECT Study
July 13, 2022 ATLANTA – Medical device company and producer of NaturalVue Multifocal 1 Day Contact Lenses, Visioneering Technologies, Inc (ASX:VTI) announced...
-
986Latest Myopia NewsVTI’s Six-Year Clinical Trial Data Published in Clinical Ophthalmology
July 8, 2022 ATLANTA — Findings from Visioneering Technologies Inc.’s (VTI) six-year myopia management clinical trial were published in the Clinical Ophthalmology journal. The study...
-
1.1KClinical
VTI’s CMO Dr. Ashley Tuan On NaturalVue and the PROTECT Study
sponsored content April 1, 2022 We believe that for myopia management, there needs to be a lot of tools in [the practitioner’s]...
-
1.9KProducts & ServicesVTI’s CMO Dr. Ashley Tuan on NaturalVue and the PROTECT Study
sponsored content March 15, 2022 Visioneering Technologies Inc. (VTI) has launched an international clinical trial that will test the efficacy of its...